Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-06-29 08:22 am Sale | 13G | Avalo Therapeutics Inc. AVTX | Caissa Capital Management ltd. | 0 0.000% | -1,475,000 (Position Closed) | View |
| 2023-04-19 4:38 pm Purchase | 13G | Avalo Therapeutics Inc. AVTX | Caissa Capital Management ltd. | 1,475,000 11.190% | 81,329 (+5.84%) | View |
| 2023-02-14 4:09 pm Purchase | 13G | Avalo Therapeutics Inc. AVTX | Caissa Capital Management ltd. | 1,393,671 10.570% | 413,113 (+42.13%) | View |
| 2022-08-08 07:23 am Sale | 13G | Avalo Therapeutics Inc. AVTX | Caissa Capital Management ltd. | 980,558 10.430% | -5,119,442 (-83.93%) | View |
| 2022-05-17 3:45 pm Purchase | 13G | Avalo Therapeutics Inc. AVTX | Caissa Capital Management ltd. | 6,100,000 5.410% | 6,100,000 (New Position) | View |